Skip to Main Content

WASHINGTON — Michelle McMurry-Heath doesn’t talk about biotech the way her peers do.

Where other executives and experts might bring up “access,” and “reimbursement,” McMurry-Heath talks about fairness and ethics.


“Science is the social justice issue of our age,” McMurry-Heath said. “Making sure that knowledge gets out to the people who need it, that, to me, is a justice issue.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Comments are closed.